Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vidit Sharma

Showing results (11-20 of 187) with videos related to

Pageof 19
Sort By:
The Journal of Urology|June 18, 2014
Open conversion during minimally invasive radical prostatectomy: impact on perioperative complications and predictors from national dataVidit Sharma, Joshua J Meeks
Lancet (London, England)|October 26, 2018
Radiotherapy for newly diagnosed oligometastatic prostate cancerLuca Boeri, Vidit Sharma, R Jeffrey Karnes
BJU International|January 24, 2018
Is it time for a more 'proactive' approach to metastatic prostate cancer?Matteo Soligo, Vidit Sharma, R Jeffrey Karnes
Urology|April 22, 2014
Implications of a 5-liter urinary bladder: inferior vena cava syndrome leading to bilateral pulmonary artery emboliVidit Sharma, Barry B McGuire, Robert B Nadler
The Journal of Urology|June 26, 2026
With great cost comes great responsibility: who will own the rising costs of bladder cancer care?Daniel D Joyce, Vidit Sharma, Stephen A Boorjian
The Journal of Urology|April 29, 2026
Are ctDNA and utDNA the new PSA for Clinically Localized Muscle Invasive Bladder Cancer in the Enfortumab Vedotin/Pembrolizumab Era?Eric V Li, Vidit Sharma, Stephen A Boorjian
Pharmacoeconomics|April 23, 2023
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the LiteratureDaniel D Joyce, Vidit Sharma, Stephen B Williams
Translational Andrology and Urology|February 15, 2020
Treatment outcomes of bladder neck contractures from surgical clip erosion: a matched cohort comparisonVidit Sharma, R Jeffrey Karnes, Boyd R Viers
European Urology Focus|July 30, 2017
Positive Pelvic Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells To Impair Tumor-reactive T CellsVidit Sharma, Haidong Dong, Eugene Kwon, et al.
Scientific Reports|February 27, 2026
An optimal multi-objective control architecture of PMSM drivesBiplab Kumar Mohapatra, Vidit Sharma, Pritam Bhowmik, et al.
Pageof 19

Showing results (11-20 of 187) with videos related to

Sort By:
Pageof 19
The Journal of Urology|June 18, 2014
Open conversion during minimally invasive radical prostatectomy: impact on perioperative complications and predictors from national dataVidit Sharma, Joshua J Meeks
Lancet (London, England)|October 26, 2018
Radiotherapy for newly diagnosed oligometastatic prostate cancerLuca Boeri, Vidit Sharma, R Jeffrey Karnes
BJU International|January 24, 2018
Is it time for a more 'proactive' approach to metastatic prostate cancer?Matteo Soligo, Vidit Sharma, R Jeffrey Karnes
Urology|April 22, 2014
Implications of a 5-liter urinary bladder: inferior vena cava syndrome leading to bilateral pulmonary artery emboliVidit Sharma, Barry B McGuire, Robert B Nadler
The Journal of Urology|June 26, 2026
With great cost comes great responsibility: who will own the rising costs of bladder cancer care?Daniel D Joyce, Vidit Sharma, Stephen A Boorjian
The Journal of Urology|April 29, 2026
Are ctDNA and utDNA the new PSA for Clinically Localized Muscle Invasive Bladder Cancer in the Enfortumab Vedotin/Pembrolizumab Era?Eric V Li, Vidit Sharma, Stephen A Boorjian
Pharmacoeconomics|April 23, 2023
Cost-Effectiveness and Economic Impact of Bladder Cancer Management: An Updated Review of the LiteratureDaniel D Joyce, Vidit Sharma, Stephen B Williams
Translational Andrology and Urology|February 15, 2020
Treatment outcomes of bladder neck contractures from surgical clip erosion: a matched cohort comparisonVidit Sharma, R Jeffrey Karnes, Boyd R Viers
European Urology Focus|July 30, 2017
Positive Pelvic Lymph Nodes in Prostate Cancer Harbor Immune Suppressor Cells To Impair Tumor-reactive T CellsVidit Sharma, Haidong Dong, Eugene Kwon, et al.
Scientific Reports|February 27, 2026
An optimal multi-objective control architecture of PMSM drivesBiplab Kumar Mohapatra, Vidit Sharma, Pritam Bhowmik, et al.
Pageof 19